Your practice can become a part of a national initiative that will allow providers to improve the quality and value of cancer care by analyzing patient records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines.

The effort has two major components:

1. The CancerLinQ^® quality improvement and data-sharing platform for oncology practices
2. CancerLinQ Discovery^®, which provides access to high-quality, de-identified data sets derived from the patient data to academic researchers, nonprofit organizations, government agencies, industry, and others in the oncology community 

The CancerLinQ database is one of the largest and most comprehensive data sets of its kind. In addition, CancerLinQ LLC has established several collaborations with government and nonprofit entities—including the American Society of Radiation Oncology, U.S. Food and Drug Administration, and National Cancer Institute—as well as industry through its collaborators AstraZeneca, Tempus, and Concerto HealthAI. These partnerships offer the CancerLinQ team guidance and insights that ultimately can contribute to the quality and efficiency of the cancer care delivery system.

For more information on how your practice can participate, stop by the CancerLinQ Booth to speak with CancerLinQ staff at the 2019 ASCO Annual Meeting (Booth #5005 in the Oncology Professionals Hall of McCormick Place).

CancerLinQ is a project of CancerLinQ LLC. Visit CancerLinQ.org for more information. CancerLinQ is supported in part by ASCO’s Conquer Cancer Foundation.